Found: 11
Select item for more details and to access through your institution.
Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 640, p. 1, doi. 10.1126/scitranslmed.abn2231
- By:
- Publication type:
- Article
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6270, doi. 10.3390/cancers13246270
- By:
- Publication type:
- Article
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17577-8
- By:
- Publication type:
- Article
The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/cells11182858
- By:
- Publication type:
- Article
Myeloid Cells during Viral Infections and Inflammation.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 2, p. 168, doi. 10.3390/v11020168
- By:
- Publication type:
- Article
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 362, doi. 10.3390/biomedicines10020362
- By:
- Publication type:
- Article
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1325558
- By:
- Publication type:
- Article
Multiplex flow cytometry-based assay for quantifying tumor-and virus-associated antibodies induced by immunotherapies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1038340
- By:
- Publication type:
- Article
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22115-1
- By:
- Publication type:
- Article
Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94483-z
- By:
- Publication type:
- Article
Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49286-x
- By:
- Publication type:
- Article